Invasive aspergillosis in a patient with aplastic anemia receiving amphotericin B.

Invasive mycotic infections are becoming more commonplace in immune-compromised hosts. Aspergillus species is the most commonly encountered fungal genus in our environment causing paranasal sinus fungal infection. Aspergillus paranasal sinus infections in the healthy host are readily treated and controlled. In the immune-compromised host this common organism can rapidly become fatal even if recognized and treated appropriately. We present a case history of a patient who died from her disease despite radical surgery and antifungicidal therapy. Recent methods for early diagnosis will be reviewed. Only one other case has been reported in the literature of a patient developing fulminant aspergillosis sinusitis while receiving amphotericin B.

[1]  S. Gerson,et al.  Serodiagnosis of invasive aspergillosis in patients with hematologic malignancy: validation of the Aspergillus fumigatus antigen radioimmunoassay. , 1987, The Journal of infectious diseases.

[2]  M. Moody,et al.  Aspergillus sinusitis in cancer patients , 1986, Cancer.

[3]  S. Krantz Special Feature: New Therapies for Aplastic Anemia , 1986 .

[4]  S. Krantz New therapies for aplastic anemia. , 1986, The American journal of the medical sciences.

[5]  V. Andriole,et al.  The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen. , 1985, The Journal of infectious diseases.

[6]  D. Shedd,et al.  Aspergillosis of the nose and paranasal sinuses in neutropenic patients at an oncology center. , 1985, Head & neck surgery.

[7]  M. Keating,et al.  Orofacial aspergillosis in acute leukemia. , 1985, Oral surgery, oral medicine, and oral pathology.

[8]  J. Gérain,et al.  Amphotericin B nasal spray as prophylaxis against aspergillosis in patients with neutropenia. , 1984, The New England journal of medicine.

[9]  S. Feig,et al.  Bone marrow transplantation from identical twins in the treatment of aplastic anaemia: implication for the pathogenesis of the disease , 1984, British journal of haematology.

[10]  S. Deresinski,et al.  Development of Aspergillus sinusitis in a patient receiving amphotericin B. Treatment with granulocyte transfusions. , 1984, The American journal of medicine.

[11]  G. Filice,et al.  Antigen detection in the diagnosis of invasive aspergillosis. Utility in controlled, blinded trials. , 1983, Annals of internal medicine.

[12]  R. Berkow,et al.  Invasive aspergillosis of paranasal tissues in children with malignancies. , 1983, The Journal of pediatrics.

[13]  R. Storb,et al.  Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis. , 1982 .

[14]  D. Winston,et al.  Prophylactic granulocyte transfusions during chemotherapy of acute nonlymphocytic leukemia. , 1981, Annals of internal medicine.

[15]  G. Healy,et al.  Fulminant aspergillosis of the nose and paranasal sinuses: A new clinical entity , 1980, The Laryngoscope.

[16]  S. Cho,et al.  Opportunistic fungal infection among cancer patients. A ten-year autopsy study. , 1979, American journal of clinical pathology.

[17]  R. Cantrell,et al.  Aspergillosis of the nose and paranasal sinuses. , 1979, American journal of otolaryngology.

[18]  A. Steere,et al.  Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. , 1979, Annals of internal medicine.

[19]  B. Andersen,et al.  Efficacy of granulocyte transfusions in the control of systemic candidiasis in the leukopenic host. , 1978, Blood.

[20]  E. Thomas,et al.  Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. , 1978, The New England journal of medicine.

[21]  P. Griner,et al.  Recovery from aplastic anemia after treatment with cyclophosphamide. , 1976, The New England journal of medicine.

[22]  J. Rowley Editorial: The role of cytogenetics in hematology. , 1976, Blood.